LegalizeS.I. No. 18/1987 - Medical Preparations (Control of Sale) Regulations, 1987
This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.
1 amending act · 1993-03-11, S.I. No. 69/1993 - Medical Preparations (Prescription and Control of Supply) Regulations, 1993
| "g" | for gram, | "mcg" | for microgram , |
| "mg" | for milligram , | "ml" | for millilitre. |
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Acebutolol Hydrochloride | B | ||
| Acecarbromal | B | ||
| Acepromazine Maleate | B | ||
| Acetanilide | B | ||
| Acetarsol | A | ||
| Acetazolamide | B | ||
| Acetazolamide Sodium | B | ||
| Acetohexamide | B | ||
| Acetophenazine Maleate | B | ||
| Acetylcholine Chloride | B | 0.2 per cent | External |
| Acetylcysteine | B | ||
| Aconite | B | 1.3 per cent | External |
| Acrosoxacin | A | ||
| Actaplanin | A | ||
| Actinomycin C | A | ||
| Actinomycin D | A | ||
| Acyclovir | A | ||
| Ardrenaline | B | (1) 0.6 per cent | (1) By inhaler (2) External |
| Adrenaline Acid Tartrate | B | (1) 1.0 per cent | (1) By inhaler (2) External |
| Adrenaline Hydrochloride | B | (1) 0.6 per cent | (1) By inhaler (2) External |
| Adrenocortical Extract | A | ||
| Alclofenac | B | ||
| Alclomethasone Dipropionate | A | ||
| Alcuronium Chloride | A | ||
| Aldosterone | A | ||
| Alfacalcidol | B | ||
| Alfentanil Hydrochloride | A | ||
| Allergen Extracts | B | ||
| Allopurinol | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Allyloestrenol | A | ||
| Almitrine | B | ||
| Aloxiprim | B | ||
| Alphadolone Acetate | A | ||
| Alphaxalone | A | ||
| Alprazolam | A | ||
| Alprenolol | B | ||
| Alprenolol Hydrochloride | B | ||
| Alprostadil | A | ||
| Alseroxylon | B | ||
| Amantadine Hydrochloride | B | ||
| Ambenonium Chloride | A | ||
| Ambutonium Bromide | B | ||
| Amcinonide | B | ||
| Ametazole Hydrochloride | B | ||
| Amethocaine | A | Any use except local ophthalmic use | |
| Amethocaine Gentisate | A | Any use except local ophthalmic use | |
| Amethocaine Hydrochloride | A | Any use except local ophthalmic use | |
| Amikacin Sulphate | A | ||
| Amiloride Hydrochloride | B | ||
| Aminocaproic Acid | B | ||
| Aminoglutethimide | B | ||
| Aminopterin Sodium | A | ||
| Amiodarone Hydrochloride | B | ||
| Amiphenazole Hydrochloride | B | ||
| Amitriptyline | A | ||
| Amitriptyline Embonate | A | ||
| Amitriptyline Hydrochloride | A | ||
| Ammonium Bromide | B | ||
| Amodiaquine Hydrochloride | B | Prophylaxis of malaria | |
| Amoxapine | A | ||
| Amoxycillin | A | ||
| Amoxycillin Trihydrate | A | ||
| Amphetamine Sulphate | A | ||
| Amphomycin Calcium | A | ||
| Amphotericin | A | ||
| Ampicillin | A | ||
| Ampicillin Sodium | A | ||
| Ampicillin Trihydrate | A | ||
| Amrinone | B | ||
| Amsacrine | A | ||
| Amygdalin | A | ||
| Amylobarbitone | A | ||
| Amylobarbitone Sodium | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Amylocaine Hydrochloride | A | Any use except local ophthalmic use | |
| Ancrod | A | ||
| Androsterone | A | ||
| Angiotensin Amide | B | ||
| Anterior Pituitary Extract | A | ||
| Antimony Barium Tartrate | B | ||
| Antimony Dimercaptosuccinate | B | ||
| Antimony Lithium Thiomalate | B | ||
| Antimony Pentasulphide | B | ||
| Antimony Potassium Tartrate | B | ||
| Antimony Sodium Tartrate | B | ||
| Antimony Sodium Thioglycollate | B | ||
| Antimony Sulphate | B | ||
| Antimony Trichloride | B | ||
| Antimony Trioxide | B | ||
| Antimony Trisulphide | B | ||
| Apiol | A | ||
| Apomorphine | B | ||
| Apomorphine Hydrochloride | B | ||
| Aprotinin | A | ||
| Arbaprostil | A | ||
| Arecoline Hydrobromide | B | ||
| Argipressin | A | ||
| Arsenic | A | ||
| Arsenic Triiodide | A | ||
| Arsenic Trioxide | A | ||
| Arsphenamine | A | ||
| Aspirin | B | ||
| Astemizole | B | ||
| Atenolol | B | ||
| Atracurium Besylate | A | ||
| Atropine | B | (1) Internal: (a) by inhaler | |
| (b) otherwise than by inhaler | |||
| (2) External (except local ophthalmic use) | |||
| Atropine Methobromide | B | (1) Internal: (a) by inhaler | |
| (b) otherwise than by inhaler | |||
| (2) External (except local ophthalmic use) | |||
| Atropine Methonitrate | B | Internal: (a) by inhaler | |
| (b) otherwise than by inhaler | |||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Atropine Oxide Hydrochloride | B | (1) Internal: (a) by inhaler | |
| (b) otherwise than by inhaler | |||
| (2) External (except local ophthalmic use) | |||
| Atropine Sulphate | B | (1) Internal: (a) by inhaler | |
| (b) otherwise than by inhaler | |||
| (2) External (except local ophthalmic use) | |||
| Auranofin | B | ||
| Azapropazone | B | ||
| Azathioprine | A | ||
| Azathioprine Sodium | A | ||
| Azidocillin Potassium | A | ||
| Azlocillin Sodium | A | ||
| Aztreonam | A | ||
| Bacampicillin Hydrochloride | A | ||
| Bacitracin | A | ||
| Bacitracin Methylene Disalicylate | A | ||
| Bacitracin Zinc | A | ||
| Baclofen | B | ||
| Barbitone | A | ||
| Barbitone Sodium | A | ||
| Barium Carbonate | B | ||
| Barium Chloride | B | ||
| Barium Sulphide | B | ||
| Beclamide | B | ||
| Beclomethasone | A | ||
| Beclomethasone Dipropionate | A | ||
| Belladonna Herb | B | (1) Internal (2) External | |
| Belladonna Root | B | (1) Internal (2) External | |
| Bemegride | B | ||
| Bemegride Sodium | B | ||
| Benapryzine Hydrochloride | B | ||
| Bendrofluazide | B | ||
| Benethamine Penicillin | A | ||
| Benorylate | B | ||
| Benoxaprofen | B | ||
| Benperidol | A | ||
| Benserazide Hydrochloride | B | ||
| Bentiromide | A | ||
| Benzathine Penicillin | A | ||
| Benzbromarone | B | ||
| Benzhexol Hydrochloride | B | ||
| Benzilonium Bromide | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Benzocaine | A | Any use except local ophthalmic use | |
| Benzoctamine Hydrochloride | B | ||
| Benzoyl Peroxide | B | 5.0 per cent | External |
| N-Benzoyl Sulphanilamide | A | ||
| Benzquinamide | B | ||
| Benzquinamide Hydrochloride | B | ||
| Benzthiazide | B | ||
| Benztropine Mesylate | B | ||
| Benzydamine Hydrochloride | B | ||
| Benzylpenicillin Calcium | A | ||
| Benzylpenicillin Potassium | A | ||
| Benzylpenicillin Sodium | A | ||
| Bepridil Hydrochloride | B | ||
| Betahistine Hydrochloride | B | ||
| Betamethasone | A | ||
| Betamethasone Adamantoate | A | ||
| Betamethasone Benzoate | A | ||
| Betamethasone Dipropionate | A | ||
| Betamethasone Sodium Phosphate | A | ||
| Betamethasone Valerate | A | ||
| Betaxolol Hydrochloride | B | ||
| Bathanechol Chloride | B | ||
| Bethanidine Sulphate | B | ||
| Bezafibrate | B | ||
| Bifonazole | B | ||
| Biperiden Hydrochloride | B | ||
| Biperiden Lactate | B | ||
| Bismuth Glycollylarsanilate | A | ||
| Bleomycin | A | ||
| Bleomycin Sulphate | A | ||
| Bornaprine Hydrochloride | B | ||
| Bretylium Tosylate | B | ||
| Bromazepam | A | ||
| Bromhexine Hydrochloride | B | ||
| Bromocriptine Mesylate | B | ||
| Bromvaletone | B | ||
| Brotizolam | A | ||
| Budesonide | A | ||
| Bufexamac | B | ||
| Buflomedil Hydrochloride | B | ||
| Bufuralol Hydrochloride | B | ||
| Bumetanide | B | ||
| Bunolol Hydrochloride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Buphenine Hydrochloride | B | ||
| Bupivacaine | A | Any use except local ophthalmic use | |
| Bupivacaine Hydrochloride | A | Any use except local ophthalmic use | |
| Buprenorphine | A | ||
| Buprenorphine Hydrochloride | A | ||
| Buserelin | A | ||
| Buspirone Hydrochloride | B | ||
| Busulphan | A | ||
| Butacaine Sulphate | A | Any use except local ophthalmic use | |
| Butobarbitone | A | ||
| Butobarbitone Sodium | A | ||
| Butorphanol Tartrate | A | ||
| Butriptyline Hydrochloride | A | ||
| Calcifediol | B | ||
| Calcitonin | B | ||
| Calcitriol | B | ||
| Calcium Amphomycin | A | ||
| Calcium Benzamidosalicylate | B | ||
| Calcium Bromide | B | ||
| Calcium Bromidolactobionate | B | ||
| Calcium Carbimide | B | ||
| Calcium Folinate | B | ||
| Calcium Metrizoate | B | ||
| Calcium Sulphaloxate | A | ||
| Camazepam | A | ||
| Candicidin | A | ||
| Canrenoic Acid | A | ||
| Cantharidin | B | 0.01 per cent | External |
| Capreomycin Sulphate | A | ||
| Captopril | B | ||
| Carbachol | B | ||
| Carbamazepine | B | ||
| Carbenicillin Sodium | A | ||
| Carbenoxolone Sodium | B | (2) 2.0 per cent | (1) Pellet (2) Gel |
| Carbidopa | B | ||
| Carbimazole | B | ||
| Carbocisteine | B | ||
| Carbon Tetrachloride | B | ||
| Carboplatin | A | ||
| Carboprost Tromethamol | A | ||
| Carbromal | B | ||
| Carbuterol Hydrochloride | B | ||
| Carfecillin Sodium | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Carindacillin Sodium | A | ||
| Carisoprodol | B | ||
| Carmustine | A | ||
| Carperidine | A | ||
| Cefaclor | A | ||
| Cefadroxil | A | ||
| Cefapirin Sodium | A | ||
| Cefazedone Sodium | A | ||
| Cefonicid Sodium | A | ||
| Cefoperazone Sodium | A | ||
| Cefotaxime Sodium | A | ||
| Cefotiam Hydrochloride | A | ||
| Cefoxitin Sodium | A | ||
| Cefsulodin Sodium | A | ||
| Ceftazidime | A | ||
| Ceftizoxime Sodium | A | ||
| Ceftriaxone Sodium | A | ||
| Cefuroxime Sodium | A | ||
| Cephalexin | A | ||
| Cephalexin Sodium | A | ||
| Cephaloridine | A | ||
| Cephalothin Sodium | A | ||
| Cephamandole Nafate | A | ||
| Cephazolin Sodium | A | ||
| Cephradine | A | ||
| Cerium Oxalate | B | ||
| Chenodeoxycholic Acid | B | ||
| Chloral Hydrate | B | External | |
| Chlorambucil | A | ||
| Chloramphenicol | A | ||
| Chloramphenicol Cinnamate | A | ||
| Chloramphenicol Palmitate | A | ||
| Chloramphenicol Sodium Succinate | A | ||
| Chlordiazepoxide | A | ||
| Chlordiazepoxide Hydrochloride | A | ||
| Chlorhexadol | B | ||
| Chlormadinone Acetate | A | ||
| Chlormerodrin | B | ||
| Chlormethiazole | A | ||
| Chlormethiazole Edisylate | A | ||
| Chlormezanone | B | ||
| Chloroform | B | (1) 5.0 per cent | (1) Internal (2) External |
| Chloroquine Phosphate | B | Prophylaxis of malaria | |
| Chloroquine Sulphate | B | Prophylaxis of malaria | |
| Chlorothiazide | B | ||
| Chlorotrianisene | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of Administration |
| Chlorphenoxamine Hydrochloride | B | ||
| Chlorpromazine | B | ||
| Chlorpromazine Embonate | B | ||
| Chlorpromazine Hydrochloride | B | ||
| Chlorpropamide | B | ||
| Chlorprothixene | B | ||
| Chlorprothixene Hydrochloride | B | ||
| Chlortetracycline | A | ||
| Chlortetracycline Calcium | A | ||
| Chlortetracycline Hydrochloride | A | ||
| Chlorthalidone | B | ||
| Chlorzoxazone | B | ||
| Cholecalciferol | B | (1) Internal (2) External | |
| Cholestyramine | B | ||
| Choline Magnesium Trisalicylate | B | ||
| Chorionic Gonadotrophin | A | ||
| Ciclacillin | A | ||
| Ciclobendazole | B | ||
| Ciclopirox | A | ||
| Cimetidine | A | ||
| Cimetidine Hydrochloride | A | ||
| Cinchocaine | B | 3.0 per cent | Any use except local ophthalmic use |
| Cinchocaine Hydrochloride | B | Equivalent of 3.0 per cent of Cinchocaine | Any use except local ophthalmic use |
| Cinchophen | B | ||
| Cinnarizine | B | ||
| Cinoxacin | A | ||
| Ciprofibrate | B | ||
| Ciprofloxacin Hydrochloride | A | ||
| Cisplatin | A | ||
| Clavulanic Acid | A | ||
| Clenbuterol Hydrochloride | B | ||
| Clidinium Bromide | B | ||
| Clindamycin | A | ||
| Clindamycin Hydrochloride | A | ||
| Clindamycin Palmitate Hydrochloride | A | ||
| Clindamycin Phosphate | A | ||
| Clioquinol | B | (1) 35mg | (1) Treatment of mouth ulcers (2) External (other than treatment of mouth ulcers) |
| Clobazam | A | ||
| Clobetasol Propionate | A | ||
| Clobetasone Butyrate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of Administration |
| Clofazimine | B | ||
| Clofibrate | B | ||
| Clomacran Phosphate | B | ||
| Clomiphene Citrate | A | ||
| Clomipramine | A | ||
| Clomipramine Hydrochloride | A | ||
| Clomocycline | A | ||
| Clomocycline Sodium | A | ||
| Clonazepam | A | ||
| Clonidine | B | ||
| Clonidine Hydrochloride | B | ||
| Clopamide | B | ||
| Clopenthixol Decanoate | B | ||
| Clopenthixol Hydrochloride | B | ||
| Clorexolone | B | ||
| Clostebol Acetate | A | ||
| Clotiazepam | A | ||
| Clotrimazole | B | External: (1) Cream (2) Powder (3) Solution | |
| Clovoxamine | A | ||
| Cloxacillin Benzathine | A | ||
| Cloxacillin Sodium | A | ||
| Cloxazolam | A | ||
| Clozapine | A | ||
| Cocaine | A | ||
| Cocaine Hydrochloride | A | ||
| Cocculus Indicus | A | ||
| Codeine Phosphate | A | Equivalent of 1.5 per cent of Codeine | |
| Co-dergocrine Mesylate | B | ||
| Colaspase | A | ||
| Colchicine | A | ||
| Colestipol Hydrochloride | B | ||
| Colistin Sulphate | A | ||
| Colistin Sulphomethate | A | ||
| Colistin Sulphomethate Sodium | A | ||
| Coniine | B | ||
| Conium Leaf | B | 7.0 per cent | External |
| Corticotrophin | A | ||
| Cortisone | A | ||
| Cortisone Acetate | A | ||
| Co-tetroxazine | A | ||
| Co-trimoxazole | A | ||
| Cropropamide | B | ||
| Crotethamide | B | ||
| Croton Oil | A | ||
| Croton Seed | A | ||
| Curare | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of Administration |
| α-Cyanobenzyl-6-O- β-D-glucopyranosyl- β-D-glucopyranoside | B | 0.1 per cent | |
| α-Cyanobenzyl-β-D-glucopyranosiduronic Acid | B | 0.1 per cent | |
| Cyanocobalamin | B | 25mcg | |
| Cyclandelate | B | ||
| Cyclobarbitone | A | ||
| Cyclobarbitone Calcium | A | ||
| Cyclofenil | A | ||
| Cyclopenthiazide | B | ||
| Cyclopentolate Hydrochloride | B | ||
| Cyclophosphamide | A | ||
| Cycloserine | A | ||
| Cyclosporin | A | ||
| Cyclothiazide | B | ||
| Cyproterone Acetate | A | ||
| Cytarabine | A | ||
| Cytarabine Hydrochloride | A | ||
| Dacarbazine | A | ||
| Danazol | B | ||
| Dantrolene Sodium | B | ||
| Dapsone | B | ||
| Dapsone Ethane Ortho Sulphonate | B | ||
| Daunorubicin Hydrochloride | A | ||
| Deanol Bitartrate | B | ||
| Debrisoquine Sulphate | B | ||
| Delorazepam | A | ||
| Demecarium Bromide | B | ||
| Demeclocycline | A | ||
| Demeclocycline Calcium | A | ||
| Demeclocycline Hydrochloride | A | ||
| Deoxycortone Acetate | A | ||
| Deoxycortone Pivalate | A | ||
| Deptropine Citrate | B | ||
| Dequalinium Chloride | B | (1) 0.25mg | (1) Internal: throat lozenges or throat pastilles |
| (2) 1.0 per cent | (2) External: paint | ||
| Deserpidine | B | ||
| Desferrioxamine Mesylate | B | ||
| Desfluorotriamcinolone | A | ||
| Desipramine Hydrochloride | A | ||
| Deslanoside | B | ||
| Desmopressin | B | ||
| Desogestrel | A | ||
| Desonide | A | ||
| Desoxymethasone | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of Administration |
| Dexamethasone | A | ||
| Dexamethasone Acetate | A | ||
| Dexamethasone Isonicotinate | A | ||
| Dexamethasone Phenylpropionate | A | ||
| Dexamethasone Pivalate | A | ||
| Dexamethasone Sodium Phosphate | A | ||
| Dexamethasone Sodium m-Sulphobenzoate | A | ||
| Dexamethasone Troxundate | A | ||
| Dexamphetamine Sulphate | A | ||
| Dexfenfluramine Hydrochloride | A | ||
| Dextromethorphan Hydrobromide | B | Internal | |
| Dextromethorphan Resinate | B | Internal | |
| Dextromoramide Hydrochloride | A | ||
| Dextromoramide Tartrate | A | ||
| Dextropropoxyphene Hydrochloride | B | ||
| Dextropropoxyphene Napsylate | B | ||
| Dextrothyroxine Sodium | B | ||
| Diazepam | A | ||
| Diazoxide | A | ||
| Dibenzepin Hydrochloride | A | ||
| Dichloralphenazone | B | ||
| Dichlorphenamide | B | ||
| Diclofenac Sodium | B | ||
| Dicylomine Hydrochloride | B | Internal (other than liquid preparations intended for infants) | |
| Dienoestrol | A | ||
| Diethanolamine Fusidate | A | ||
| Diethylcarbamazine | B | ||
| Diethylcarbamazine Citrate | B | ||
| Diethylpropion Hydrochloride | A | ||
| Difenoxin Hydrochloride | A | ||
| Diflucortolone Valerate | A | ||
| Diflunisal | B | ||
| Digitalin | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of Administration |
| Digitalis Leaf | B | ||
| Digitalis Prepared | B | ||
| Digitoxin | B | ||
| Digoxin | B | ||
| Dihydralazine Sulphate | B | ||
| Dihydrocodeine Tartrate | A | Equivalent of 1.5 per cent of Dihydrocodeine | |
| Dihydroergotamine Mesylate | B | ||
| Dihydrostreptomycin | A | ||
| Dihydrostreptomycin Sulphate | A | ||
| Dihydrotachysterol | B | 0.075mg (MDD) | |
| Di-iodohydroxyquinoline | B | ||
| Diloxanide Furoate | B | ||
| Diltiazem Hydrochloride | A | ||
| Dimercaprol | B | ||
| Dimethisoquin Hydrochloride | B | Any use except local ophthalmic use | |
| Dimethisterone | A | ||
| Dimethothiazine Mesylate | B | ||
| Dimethyl Sulphoxide | A | ||
| Dimethyltubocurarine Bromide | A | ||
| Dimethyltubocurarine Chloride | A | ||
| Dimethyltubocurarine Iodide | A | ||
| Dinoprost | A | ||
| Dinoprost Trometamol | A | ||
| Dinoprostone | A | ||
| Diphenoxylate Hydrochloride | B | ||
| Dipipanone Hydrochloride | A | ||
| Dipyridamole | B | ||
| Disopyramide | B | ||
| Disopyramide Phosphate | B | ||
| Distigmine Bromide | B | ||
| Disulfiram | B | ||
| Dithranol | B | 1.0 per cent | |
| Dobutamine Hydrochloride | B | ||
| Domperidone | B | ||
| Dopamine Hydrochloride | A | ||
| Dothiepin | A | ||
| Dothiepin Hydrochloride | A | ||
| Doxapram Hydrochloride | A | ||
| Doxazosin Mesylate | A | ||
| Doxepin Hydrochloride | A | ||
| Doxorubicin | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Doxycycline | A | ||
| Docycycline Calcium Chelate | A | ||
| Doxycycline Hydrochloride | A | ||
| Doxylamine Succinate | B | ||
| Droperidol | A | ||
| Drostanolone | A | ||
| Drostanolone Propionate | A | ||
| Dydrogesterone | A | ||
| Dyflos | B | ||
| Econazole | B | External (except vaginal use) | |
| Econazole Nitrate | B | External (except vaginal use) | |
| Ecothiopate Iodide | A | ||
| Edrophonium Chloride | A | ||
| Embutramide | A | ||
| Emepronium Bromide | B | ||
| Emetine | B | 1.0 per cent | |
| Emetine Bismuth Iodide | B | ||
| Emetine Hydrochloride | B | Equivalent of 1.0 per cent of Emetine | |
| Encainide | B | ||
| Endralazine | B | ||
| Enoximone | A | ||
| Ephedrine | B | External (except local ophthalmic use) | |
| Ephedrine Hydrochloride | B | External (except local ophthalmic use) | |
| Ephedrine Sulphate | B | External (except local ophthalmic use) | |
| Epicillin | A | ||
| Epithiazide | B | ||
| Epoprostenol | |||
| Sodium | A | ||
| Ergocalciferol | B | ||
| Ergometrine Maleate | B | ||
| Ergometrine Tartrate | B | ||
| Ergot, Prepared | B | ||
| Ergotamine Tartrate | B | ||
| Erythromycin | A | ||
| Erythromycin Estolate | A | ||
| Erythromycin Ethyl Carbonate | A | ||
| Erythromycin Ethyl Succinate | A | ||
| Erythromycin Lactobionate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Erythromycin Phosphate | A | ||
| Erythromycin Stearate | A | ||
| Erythromycin Thiocyanate | A | ||
| Estazolam | A | ||
| Estramustine Phosphate | A | ||
| Etafedrine Hydrochloride | B | ||
| Ethacrynic Acid | B | ||
| Ethambutol Hydrochloride | B | ||
| Ethamivan | B | ||
| Ethamsylate | B | ||
| Ethchlorvynol | B | ||
| Ethebenecid | B | ||
| Ethiazide | B | ||
| Ethinyl Androstenediol | A | ||
| Ethinyloestradiol | A | ||
| Ethionamide | B | ||
| Ethisterone | A | ||
| Ethoglucid | A | ||
| Ethoheptazine Citrate | A | ||
| Ethopropazine Hydrochloride | A | ||
| Ethosuximide | B | ||
| Ethotoin | B | ||
| Ethyl Biscoumacetate | B | ||
| Ethyl Loflazepate | A | ||
| Ethylmorphine Hydrochloride | A | Equivalent of 0.2 per cent of Ethylmorphine | |
| Ethyloestrenol | A | ||
| Ethynodiol Diacetate | A | ||
| Etidronate Disodium | B | ||
| Etifoxine | A | ||
| Etodolac | B | ||
| Etofenamate | B | ||
| Etomidate | A | ||
| Etoposide | A | ||
| Etorphine | |||
| Hydrochloride | A | ||
| Etretinate | B | ||
| Famotidine | A | ||
| Fazadinium | |||
| Bromide | A | ||
| Felodipine | A | ||
| Felypressin | A | ||
| Fenbufen | B | ||
| Fencamfamin Hydrochloride | A | ||
| Fenclofenac | B | ||
| Fenfluramine Hydrochloride | A | ||
| Fenofibrate | B | ||
| Fenoprofen | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Fenoprofen Calcium | B | ||
| Fenoterol Hydrobromide | B | ||
| Fentanyl Citrate | A | ||
| Feprazone | B | ||
| Ferrous Arsenate | B | ||
| Flavoxate Hydrochloride | B | ||
| Flecainide Acetate | B | ||
| Floctafenine | B | ||
| Fluanisone | A | ||
| Flubendazole | B | ||
| Fluclorolone Acetonide | A | ||
| Flucloxacillin Sodium | A | ||
| Flucytosine | A | ||
| Fludiazepam | A | ||
| Fludrocortisone Acetate | A | ||
| Flufenamic Acid | B | ||
| Flumethasone | A | ||
| Flumethasone Pivalate | A | ||
| Flunarizine Hydrochloride | B | ||
| --- | --- | --- | --- |
| Flunisolide | A | ||
| --- | --- | --- | --- |
| Flunitrazepam | A | ||
| Fluocinolone Acetonide | A | ||
| Fluocinonide | A | ||
| Fluocortin Butyl | A | ||
| Fluocortolone | A | ||
| Fluocortolone Hexanoate | A | ||
| Fluocortolone Pivalate | A | ||
| Fluorometholone | A | ||
| Fluorouracil | A | ||
| Fluorouracil Trometamol | A | ||
| Fluoxetine | A | ||
| Fluoxymesterone | A | ||
| Flupenthixol Decanoate | B | ||
| Flupenthixol Hydrochloride | B | ||
| Fluperolone Acetate | A | ||
| Fluphenazine Decanoate | B | ||
| Fluphenazine Enanthate | B | ||
| Fluphenazine Hydrochloride | B | ||
| Fluprednidene Acetate | A | ||
| Fluprednisolone | A | ||
| Fluprostenol Sodium | A | ||
| Flurandrenolone | A | ||
| Flurazepam Hydrochloride | A | ||
| Flurazepam Monohydrochloride | A | ||
| Flurbiprofen | B | ||
| Fluspirilene | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Flutamide | A | ||
| Fluvoxamine Maleate | B | ||
| Folic Acid | B | ||
| Formocortal | A | ||
| Foscarnet Sodium | A | ||
| Fosfestrol Sodium | A | ||
| Framycetin Sulphate | A | ||
| Frusemide | B | ||
| Furazolidone | B | ||
| Fusafungine | A | ||
| Fusidic Acid | A | ||
| Gallamine Triethiodide | A | ||
| Gelsemine | B | 0.1 per cent | |
| Gelsemium | B | ||
| Gentamicin | A | ||
| Gentamicin Sulphate | A | ||
| Gestronol | A | ||
| Gestronol Hexanoate | A | ||
| Ginkgo biloba | B | ||
| Glibenclamide | B | ||
| Glibornuride | B | ||
| Gliclazide | B | ||
| Glipizide | B | ||
| Gliquidone | B | ||
| Glisoxepide | B | ||
| Glucagon | B | ||
| Glutethimide | A | ||
| Glyceryl Trinitrate | B | ||
| Glycopyrronium Bromide | B | ||
| Glymidine | B | ||
| Gonadorelin | A | ||
| Gramicidin | A | 0.2 per cent | External |
| Griseofulvin | A | ||
| Growth Hormone | A | ||
| Guanacline Sulphate | B | ||
| Guanethidine Monosulphate | B | ||
| Guanfacine Hydrochloride | B | ||
| Guanoclor Sulphate | B | ||
| Guanoxan Sulphate | B | ||
| Halazepam | A | ||
| Halcinonide | A | ||
| Haloperidol | A | ||
| Haloperidol Decanoate | A | ||
| Haloxazolam | A | ||
| Harmine | A | ||
| Heparin | A | External | |
| Heparin Calcium | A | External | |
| Heptabarbitone | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Hexachlorophane | B | External: | |
| (a) 2.0 per cent (b) 0.1 per cent (c) 0.75 per cent | (a) soaps (b) aerosols (c) preparations other than soaps and aerosols | ||
| Hexamethonium Bromide | A | ||
| Hexamethonium Iodide | A | ||
| Hexamethonium Tartrate | A | ||
| Hexamine Phenylcinchoninate | B | ||
| Hexobarbitone | A | ||
| Hexobarbitone Sodium | A | ||
| Hexoestrol | A | ||
| Hexoestrol Dipropionate | A | ||
| L-Histidine Hydrochloride | B | Dietary or nutritive use | |
| Homatropine | B | (1) Internal | |
| (2) External (except local ophthalmic use) | |||
| Homatropine Hydrobromide | B | ||
| Homatropine Methylbromide | B | ||
| Hydralazine Hydrochloride | B | ||
| Hydrargaphen | B | Local application to skin | |
| Hydrobromic Acid | B | ||
| Hydrochlorothiazide | B | ||
| Hydrocodone Resinate | A | ||
| Hydrocodone Tartrate | A | ||
| Hydrocortisone | A | ||
| Hydrocortisone Acetate | A | ||
| Hydrocortisone Butyrate | A | ||
| Hydrocortisone Caprylate | A | ||
| Hydrocortisone Hydrogen Succinate | A | ||
| Hydrocortisone Sodium Phosphate | A | ||
| Hydrocortisone Sodium Succinate | A | ||
| Hydroflumethiazide | B | ||
| Hydromorphone Hydrochloride | A | ||
| Hydroxocobalamin | B | ||
| Hydroxychloroquine Sulphate | B | Prophylaxis of malaria | |
| Hydroxyprogesterone | A | ||
| Hydroxyprogesterone Enanthate | A | ||
| Hydroxyprogesterone Hexanoate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Hydroxyurea | A | ||
| Hydroxyzine | |||
| Embonate | B | ||
| Hydroxyzine Hydrochloride | B | ||
| Hyoscine | B | (1) 0.15 per cent | (1) Internal |
| (2) External (except local ophthalmic use) | |||
| Hyoscine Butylbromide | B | ||
| (1) Internal: | |||
| (a) By inhaler | |||
| (b) Otherwise than by inhaler | |||
| (2) External | |||
| Hyoscine Hydrobromide | B | (1) Internal: | |
| (a) By inhaler | |||
| (b) Otherwise than by inhaler | |||
| (2) External (except local ophthalmic use) | |||
| Hyoscine Methobromide | B | (1) Internal: | |
| (a) By inhaler | |||
| (b) Otherwise than by inhaler | |||
| (2) External | |||
| Hyoscine Methonitrate | B | (1) Internal: | |
| (a) By inhaler | |||
| (b) Otherwise than by inhaler | |||
| (2) External | |||
| Hyoscyamine | B | (1) Internal: | |
| (a) By inhaler | |||
| (b) Otherwise than by inhaler | |||
| (2) External | |||
| (3) Preparations for the relief of asthma in the form of cigarettes, smoking mixtures or fumigants which contain Hyoscyamine as an alkaloid of Stramonium | |||
| Hyoscyamine Hydrobromide | B | (1) Internal: | |
| (a) By inhaler | |||
| (b) Otherwise than by inhaler | |||
| (2)External | |||
| Hyoscyamine Sulphate | B | (1) Internal: | |
| (a) By inhaler | |||
| (b) Otherwise than by inhaler | |||
| (2) External | |||
| Ibuprofen | A | Rheumatic and muscular pain, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza | |
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Idoxuridine | A | ||
| Ifosfamide | A | ||
| Ignatius Bean | B | ||
| Imipramine | A | ||
| Imipramine Hydrochloride | A | ||
| Imipramine Resinate | A | ||
| Impromidine Hydrochloride | A | ||
| Indapamide Hemihydrate | B | ||
| Indomethacin | B | ||
| Indoprofen | B | ||
| Indoramin Hydrochloride | B | ||
| Inosine Pranobex | A | ||
| Interferon Alfa | A | ||
| Interferon Beta | A | ||
| Interferon Gamma | A | ||
| Iodamide | B | ||
| Iodamide Meglumine | B | ||
| Iodamide Sodium | B | ||
| Iopamidol | B | ||
| Iopromide | B | ||
| Ipratropium Bromide | B | ||
| Iprindole Hydrochloride | A | ||
| Iproniazid Phosphate | A | ||
| Isoaminile | B | ||
| Isoaminile Citrate | B | ||
| Isocarboxazid | A | ||
| Isoconazole Nitrate | B | External | |
| (except vaginal use) | |||
| Isoetharine | B | ||
| Isoetharine | |||
| Hydrochloride | B | ||
| Isoetharine Mesylate | B | ||
| Isoniazid | B | ||
| Isoprenaline Hydrochloride | B | ||
| Isoprenaline Sulphate | B | ||
| Isopropamide Iodide | B | ||
| Isotretinoin | A | ||
| Isoxicam | B | ||
| Isoxsuprine Hydrochloride | B | ||
| Jaborandi | B | External | |
| Kanamycin Sulphate | A | ||
| Ketamine Hydrochloride | A | ||
| Ketazolam | A | ||
| Ketoconazole | B | ||
| Ketoprofen | B | ||
| Ketotifen Fumarate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Labetolol Hydrochloride | B | ||
| Lanatoside C | B | ||
| Lanatoside Complex A, B and C | B | ||
| Latamoxef Disodium | A | ||
| Leuprorelin Acetate | A | ||
| Levallorphan Tartrate | B | ||
| Levamisole | A | ||
| Levamisole Hydrochloride | B | ||
| Levodopa | A | ||
| Levonorgestrel | A | ||
| Levorphanol Tartrate | A | ||
| Lidoflazine | A | ||
| Lignocaine | A | Any use | |
| except local | |||
| ophthalmic use | |||
| Lignocaine Hydrochloride | A | Any use | |
| except local | |||
| ophthalmic use | |||
| Lincomycin | A | ||
| Lincomycin Hydrochloride | A | ||
| Liothyronine Sodium | B | ||
| Lisinopril | B | ||
| Lisuride Maleate | B | ||
| Lithium Carbonate | A | ||
| Lithium Sulphate | A | ||
| Lobeline | B | (1) Internal | |
| (2) External | |||
| Lobeline Hydrochloride | B | (1) Internal | |
| (2) External | |||
| Lobeline Sulphate | B | (1) Internal | |
| (2) External | |||
| Lofepramine | A | ||
| Lomustine | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Loperamide Hydrochloride | B | Treatment of acute diarrhoea | |
| Loprazolam Mesylate | A | ||
| Lorazepam | A | ||
| Lormetazepam | A | ||
| Loxapine | B | ||
| Loxapine Succinate | B | ||
| Luteinising Hormone | A | ||
| Lymecycline | A | ||
| Lynoestrenol | A | ||
| Lypressin | A | ||
| Mafenide | A | ||
| Mafenide Acetate | A | ||
| Mafenide Hydrochloride | A | ||
| Mafenide Propionate | A | 5.0 per cent | Eye drops |
| Magnesium Fluoride | B | ||
| Magnesium Metrizoate | B | ||
| Mandragora Autumnalis | B | ||
| Mannomustine Hydrochloride | A | ||
| Maprotiline Hydrochloride | B | ||
| Mazindol | A | ||
| Mebanazine | A | ||
| Mebendazole | B | ||
| Mebeverine Hydrochloride | B | ||
| Mebhydrolin | B | ||
| Mebhydrolin Napadisylate | B | ||
| Mecamylamine Hydrochloride | B | ||
| Mecillinam | A | ||
| Meclofenoxate | |||
| Hydrochloride | B | ||
| Medazepam | A | ||
| Medicinal Opium | A | (1) Equivalent of 0.02 per cent of anhydrous morphine | (1) Liquids |
| (2) Equivalent of 0.04 per cent of anhydrous morphine | (2) Solids | ||
| Medigoxin | B | ||
| Medrogestone | A | ||
| Medroxyprogesterone Acetate | A | ||
| Medrysone | A | ||
| Mefenamic Acid | B | ||
| Mefruside | B | ||
| Megestrol | A | ||
| Megestrol Acetate | A | ||
| Meglumine Iodoxamate | B | ||
| Meglumine Ioglycamate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Meglumine Iotroxate | B | ||
| Melphalan | A | ||
| Melphalan Hydrochloride | A | ||
| Menotrophin | A | ||
| Mepenzolate Bromide | B | ||
| Mephenesin | B | ||
| Mephenesin Carbamate | B | ||
| Mepindolol | B | ||
| Mepivacaine Hydrochloride | A | Any use except local ophthalmic use | |
| Meprobamate | B | ||
| Meptazinol Hydrochloride | A | ||
| Mequitazine | B | ||
| Mercaptopurine | A | ||
| Mercuric Chloride | B | ||
| Mercuric Iodide | B | ||
| Mersalyl | B | ||
| Mersalyl Acid | B | ||
| Mesterolone | A | ||
| Mestranol | A | ||
| Metaraminol Tartrate | B | ||
| Metergoline | A | ||
| Metformin Hydrochloride | B | ||
| Methacycline | A | ||
| Methacycline Calcium | A | ||
| Methacycline Hydrochloride | A | ||
| Methadone Hydrochloride | A | ||
| Methallenoestril | A | ||
| Methandienone | A | ||
| Methapyrilene Fumarate | A | ||
| Methapyrilene Hydrochloride | A | ||
| Methaqualone | A | ||
| Methicillin Sodium | A | ||
| Methixene | B | ||
| Methixene Hydrochloride | B | ||
| Methocarbamol | B | ||
| Methocidin | A | Throat lozenges and throat pastilles | |
| Methohexitone Sodium | A | ||
| Methoin | B | ||
| Methoserpidine | B | ||
| Methotrexate | A | ||
| Methotrexate Sodium | A | ||
| Methotrimeprazine | B | ||
| Methotrimeprazine Hydrochloride | B | ||
| Methotrimeprazine Maleate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Methoxamine Hydrochloride | B | 0.25 per cent | Nasal sprays or nasal drops not containing liquid paraffin as a vehicle |
| Methsuximide | B | ||
| Methyclothiazide | B | ||
| Methylamphetamine Hydrochloride | A | ||
| Methyldopa | B | ||
| Methyldopate Hydrochloride | B | ||
| Methylephedrine Hydrochloride | B | ||
| Methylphenidate Hydrochloride | A | ||
| Methylphenobarbitone | A | ||
| Methylprednisolone | A | ||
| Methylprednisolone Acetate | A | ||
| Methylprednisolone Sodium Succinate | A | ||
| Methyltestosterone | A | ||
| Methylthiouracil | B | ||
| Methyprylone | A | ||
| Methysergide Maleate | B | ||
| Metirosine | A | ||
| Metoclopramide Hydrochloride | B | ||
| Metolazone | B | ||
| Metoprolol Tartrate | B | ||
| Metronidazole | B | ||
| Metyrapone | B | ||
| Mexiletine Hydrochloride | B | ||
| Mezlocillin Sodium | A | ||
| Mianserin Hydrochloride | B | ||
| Miconazole | B | External (except vaginal use) | |
| Miconazole Nitrate | B | External (except vaginal use) | |
| Midazolam | A | ||
| Minocycline | A | ||
| Minocycline Hydrochloride | A | ||
| Minoxidil | B | ||
| Misoprostol | A | ||
| Mithramycin | A | ||
| Mitobronitol | A | ||
| Mitomycin C | A | ||
| Mitozantrone Hydrochloride | A | ||
| Molindone Hydrochloride | B | ||
| Molsidomine | B | ||
| Mopidamol | A | ||
| Morazone Hydrochloride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Morphine Hydrochloride | A | (1) Equivalent of 0.02 per cent of anhydrous morphine | (1) Liquids |
| (2) Equivalent of 0.04 per cent of anhydrous morphine; equivalent of 300 mcg of anhydrous morphine | (2) Solids | ||
| Morphine Sulphate | A | (1) Equivalent of 0.02 per cent of anhydrous morphine | (1) Liquids |
| (2)Equivalent of 0.04 per cent of anhydrous morphine; equivalent of 300mcg of anhydrous morphine | (2) Solids | ||
| Mupirocin | A | ||
| Mustine Hydrochloride | A | ||
| Nabilone | A | ||
| Nabumetone | B | ||
| Nadolol | B | ||
| Naftidrofuryl Oxalate | B | ||
| Nalbuphine Hydrochloride | A | ||
| Nalidixic Acid | B | ||
| Nalorphine Hydrobromide | A | ||
| Nalorphine Hydrochloride | A | ||
| Naloxone Hydrochloride | A | ||
| Naltrexone Hydrochloride | A | ||
| Nandrolone Decanoate | A | ||
| Nandrolone Laureate | A | ||
| Nandrolone Phenylpropionate | A | ||
| Naphazoline Hydrochloride | B | (1) 0.05 per cent | (1) Nasal sprays or nasal drops not containing liquid paraffin as a vehicle |
| (2) 0.015 per cent | (2) Eye drops | ||
| Naphazoline Nitrate | B | 0.05 per cent | Nasal sprays or nasal drops not containing liquid paraffin as a vehicle |
| Naproxen | B | ||
| Naproxen Sodium | B | ||
| Natamycin | A | ||
| Nedocromil Sodium | B | ||
| Nefopam Hydrochloride | B | ||
| Neomycin | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Neomycin Oleate | A | ||
| Neomycin Palmitate | A | ||
| Neomycin Sulphate | A | ||
| Neomycin Undecanoate | A | ||
| Neostigmine Bromide | B | ||
| Neostigmine Methylsulphate | B | ||
| Netilmicin Sulphate | A | ||
| Nialamide | A | ||
| Nicardipine Hydrochloride | B | ||
| Niclosamide | B | ||
| Nicotine Resinate | B | ||
| Nicoumalone | B | ||
| Nifedipine | B | ||
| Nifenazone | B | ||
| Nikethamide | B | ||
| Nimetazepam | A | ||
| Nimodipine | B | ||
| Nimorazole | B | ||
| Niridazole | B | ||
| Nitrazepam | A | ||
| Nitrofurantoin | B | ||
| Nitrofurazone | B | ||
| Nizatidine | A | ||
| Nomifensine Maleate | A | ||
| Noradrenaline | B | ||
| Noradrenaline Acid Tartrate | B | ||
| Nordiazepam | A | ||
| Norethandrolone | A | ||
| Norethisterone | A | ||
| Norethisterone Acetate | A | ||
| Norethisterone Heptanoate | A | ||
| Norethynodrel | A | ||
| Norfloxacin | A | ||
| Norgestrel | A | ||
| Nortriptyline Hydrochloride | A | ||
| Novobiocin Calcium | A | ||
| Novobiocin Sodium | A | ||
| Nux Vocima Seed | B | ||
| Nystatin | A | ||
| Octacosactrin | A | ||
| Oestradiol | A | ||
| Oestradiol Benzoate | A | ||
| Oestradiol Cypionate | A | ||
| Oestradiol Dipropionate | A | ||
| Oestradiol Diundecanoate | A | ||
| Oestradiol Enanthate | A | ||
| Oestradiol Phenylpropionate | A | ||
| Oestradiol Undecanoate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Oestradiol Valerate | A | ||
| Oestriol | A | ||
| Oestriol Di-Hemisuccinate | A | ||
| Oestrogenic Substances Conjugated | A | ||
| Oestrone | A | ||
| Omeprazole | B | ||
| Opipramol Hydrochloride | A | ||
| Orciprenaline Sulphate | B | ||
| Orphenadrine Citrate | B | ||
| Orphenadrine Hydrochloride | B | ||
| Ouabain | B | ||
| Ovarian Gland Dried | A | ||
| Oxamniquine | B | ||
| Oxandrolone | A | ||
| Oxantel Pamoate | B | ||
| Oxatomide | B | ||
| Oxazepam | A | ||
| Oxazolam | A | ||
| Oxiconazole Nitrate | B | ||
| Oxedrine Tartrate | B | ||
| Oxolinic Acid | B | ||
| Oxpentifylline | B | ||
| Oxprenolol Hydrochloride | B | ||
| Oxybuprocaine Hydrochloride | B | Any use except local ophthalmic use | |
| Oxycodone Hydrochloride | A | ||
| Oxycodone | A | ||
| Pectinate Oxymetholone | A | ||
| Oxypertine | B | ||
| Oxypertine Hydrochloride | B | ||
| Oxyphenbutazone | B | ||
| Oxyphencyclimine Hydrochloride | B | ||
| Oxyphenonium Bromide | B | ||
| Oxytetracycline | A | ||
| Oxytetracycline Calcium | A | ||
| Oxytetracycline Dihydrate | A | ||
| Oxytetracycline Hydrochloride | A | ||
| Oxytocin, natural | B | ||
| Oxytocin, synthetic | B | ||
| Pancuronium Bromide | A | ||
| Papaveretum | A | ||
| Papaverine | B | (1) By inhaler | |
| (2) otherwise than by inhaler | |||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Papaverine Hydrochloride | B | (1) By inhaler | |
| (2) otherwise than by inhaler | (2) Equivalent of50mg of Papaverine (MD) | ||
| Paracetamol | B | ||
| Paraldehyde | B | ||
| Paramethadione | B | ||
| Paramethasone Acetate | A | ||
| Parathyroid Gland | A | ||
| Pargyline Hydrochloride | A | ||
| Pecilocin | A | ||
| Pemoline | A | ||
| Pempidine Tartrate | B | ||
| Penamecillin | A | ||
| Penbutolol Sulphate | B | ||
| Penfluridol | A | ||
| Penicillamine | B | ||
| Penicillamine Hydrochloride | B | ||
| Pentagastrin | A | ||
| Pentazocine Hydrochloride | A | ||
| Pentazocine Lactate | A | ||
| Penthienate Methobromide | B | ||
| Pentobarbitone | A | ||
| Pentobarbitone Sodium | A | ||
| Pentolinium Tartrate | B | ||
| Perhexiline Maleate | B | ||
| Pericyazine | B | ||
| Permethrin | B | ||
| Perphenazine | B | ||
| Pethidine Hydrochloride | A | ||
| Phenacetin | A | 0.1 per cent | External |
| Phenazone | B | External | |
| Phenazone Salicylate | B | ||
| Phenazone and Caffeine Citrate | B | ||
| Phenbutrazate Hydrochloride | A | ||
| Phenelzine Sulphate | A | ||
| Phenethicillin Potassium | A | ||
| Phenformin Hydrochloride | B | ||
| Phenglutarimide Hydrochloride | B | ||
| Phenindione | B | ||
| Phenmetrazine Hydrochloride | A | ||
| Phenobarbitone | A | ||
| Phenobarbitone Sodium | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Phenoperidine Hydrochloride | A | ||
| Pheothrim | B | ||
| Phenoxybenzamine Hydrochloride | B | ||
| Phenoxymethylpenicillin | A | ||
| Phenoxymethylpenicillin Calcium | A | ||
| Phenoxymethylpenicillin Potassium | A | ||
| Phenprocoumon | B | ||
| Phensuximide | B | ||
| Phentermine Hydrochloride | A | ||
| Phentermine Resinate | A | ||
| Phentolamine Hydrochloride | B | ||
| Phentolamine Mesylate | B | ||
| Phenylbutazone | A | ||
| Phenylbutazone Sodium | A | ||
| Phenylephrine Hydrochloride | B | (1) Internal (other than controlled release capsules and tablets, nasal sprays and nasal drops) | |
| (2) controlled release capsules and tablets | |||
| (3) 0.5 per cent | (3) nasal sprays and nasal drops | ||
| (4) External (except local ophthalmic use) | |||
| PhenylmethylbarbituricAcid | A | ||
| Phenylpropanolamine Hydrochloride | B | Internal: (1) all preparations except controlled release capsules, nasal sprays and nasal drops | |
| (2) controlled release capsules | |||
| (3) 2.0 per cent | (3) nasal sprays and nasal drops | ||
| Phenytoin | B | ||
| Phenytoin Sodium | B | ||
| Pholcodine | B | 1.5 per cent | |
| Pholcodine Citrate | B | Equivalent of 1.5 per cent of Pholcodine | |
| Pholcodine Tartrate | B | Equivalent of1.5 per cent of Pholcodine | |
| Phthalylsulphathiazole | B | ||
| Physostigmine | B | ||
| Physostigmine Aminoxide Salicylate | B | ||
| Physostigmine Salicylate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Physostigmine Sulphate | B | ||
| Picrotoxin | B | ||
| Pilocarpine | B | ||
| Pilocarpine Hydrochloride | B | ||
| Pilocarpine Nitrate | B | ||
| Pimozide | B | ||
| Pinacidil | B | ||
| Pinazepam | A | ||
| Pindolol | B | ||
| Pipenzolate Bromide | B | ||
| Piperacillin Sodium | A | ||
| Piperazine Oestrone Sulphate | A | ||
| Piperidolate Hydrochloride | B | ||
| Pipothiazine Palmitate | B | ||
| Pipradrol Hydrochloride | A | ||
| Piracetam | B | ||
| Pirbuterol Acetate | B | ||
| Pirbuterol Hydrochloride | B | ||
| Pirenzepine Hydrochloride | A | ||
| Piretanide | B | ||
| Piritramide | A | ||
| Piromidic Acid | A | ||
| Piroxicam | B | ||
| Pirprofen | B | ||
| Pituitary Gland (Whole Dried) | B | ||
| Pituitary Powdered (Posterior Lobe) | B | ||
| Pivampicillin Hydrochloride | A | ||
| Pivmecillinam | A | ||
| Pivmecillinam Hydrochloride | A | ||
| Pizotifen | B | ||
| Pizotifen Maleate | B | ||
| Podophyllum | B | ||
| Podophyllum Indian | B | ||
| Podophyllum Resin | B | 20.0 per | External |
| cent | |||
| Poldine Methylsulphate | B | ||
| Polidexide | B | ||
| Polyestradiol Phosphate | A | ||
| Polymyxin B Sulphate | A | ||
| Polythiazide | B | ||
| Poppy Capsule | A | ||
| Potassium Arsenite | B | 0.0127 | |
| per cent | |||
| Potassim Bromide | B | ||
| Potassium Canrenoate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Potassium Clorazepate | A | ||
| Potassium Perchlorate | B | ||
| Practolol | B | ||
| Pralidoxime Chloride | B | ||
| Pralidoxime Iodide | B | ||
| Pralidoxime Mesylate | B | ||
| Prazepam | A | ||
| Prazosin Hydrochloride | B | ||
| Prednisolone | A | ||
| Prednisolone Acetate | A | ||
| Prednisolone Butylacetate | A | ||
| Prednisolone Hexanoate | A | ||
| Prednisolone Pivalate | A | ||
| Prednisolone Sodium Phosphate | A | ||
| Prednisolone Sodium m- Sulphobenzoate | A | ||
| Prednisolone 21-Steaglate | A | ||
| Prednisolone m-Sulphobenzoate | A | ||
| Prednisone | A | ||
| Prednisone Acetate | A | ||
| Prenalterol Hydrochloride | B | ||
| Prenylamine Lactate | B | ||
| Prilocaine Hydrochloride | A | Any use except local ophthalmic use | |
| Primidone | B | ||
| Probenecid | B | ||
| Probucol | B | ||
| Procainamide Hydrochloride | B | ||
| Procaine Hydrochloride | A | Any use except local ophthalmic use | |
| Procaine Penicillin | A | ||
| Procarbazine Hydrochloride | A | ||
| Procaterol Hyrdochloride | B | ||
| Prochlorperazine Edisylate | B | ||
| Prochlorperazine Maleate | B | ||
| Prochlorperazine | |||
| Mesylate | B | ||
| Procyclidine Hydrochloride | B | ||
| Progesterone | A | ||
| Proguanil Hydrochloride | B | Prophylaxis of malaria | |
| Prolactin | A | ||
| Proligestone | A | ||
| Prolintane Hydrochloride | A | ||
| Promazine Embonate | B | ||
| Promazine Hydrochloride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Propafenone Hydrochloride | B | ||
| Propanidid | B | ||
| Propantheline Bromide | B | ||
| Propizepine | A | ||
| Propofol | A | ||
| Propranolol Hydrochloride | B | ||
| Propylthiouracil | B | ||
| Proquazone | B | ||
| Proscillaridin | B | ||
| Protamine Sulphate | B | ||
| Prothionamide | B | ||
| Protirelin | B | ||
| Protriptyline Hydrochloride | A | ||
| Proxymetacaine Hydrochloride | B | Any use except local ophthalmic use | |
| Pseudoephedrine Hydrochloride | B | Internal: (1)All preparations except controlled release capsules and tablets | |
| (2) Controlled release capsules and tablets | |||
| Pseudoephedrine Sulphate | B | Internal: (1) All preparations except controlled release capsules and tablets | |
| (2) Controlled release capsules and tablets | |||
| Pyrantel Embonate | B | ||
| Pyrantel Tartrate | B | ||
| Pyrazinamide | B | ||
| Pyridostigmine Bromide | B | ||
| Pyridoxine Hydrochloride | B | ||
| Pyrimethamine | B | ||
| Quazepam | A | ||
| Quinalbarbitone | A | ||
| Quinalbarbitone Sodium | A | ||
| Quinestradol | A | ||
| Quinestrol | A | ||
| Quinethazone | B | ||
| Quinidine | B | ||
| Quinidine Bisulphate | B | ||
| Quinidine Phenylethylbarbiturate | A | ||
| Quinidine Polygalacturonate | B | ||
| Quinidine Sulphate | B | ||
| Quinine | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Quinine Bisulphate | B | ||
| Quinine Dihydrochloride | B | ||
| Quinine Ethyl Carbonate | B | ||
| Quinine Glycerophosphate | B | ||
| Quinine Hydrobromide | B | ||
| Quinine Hydrochloride | B | ||
| Quinine Iodobismuthate | B | ||
| Quinine Phenylcinchoninate | B | ||
| Quinine Phosphate | B | ||
| Quinine Salicylate | B | ||
| Quinine Sulphate | B | ||
| Quinine Tannate | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Quinine and Urea Hydrochloride | B | ||
| Ranitidine Hydrochloride | A | ||
| Rauwolfia Serpentina | B | ||
| Rauwolfia Vomitoria | B | ||
| Razoxane | A | ||
| Reproterol Hydrochloride | B | ||
| Rescinnamine | B | ||
| Reserpine | B | ||
| Rifampicin | A | ||
| Rifamycin | A | ||
| Rimiterol Hydrobromide | B | ||
| Ritodrine Hydrochloride | B | ||
| Rolitetracycline Nitrate | A | ||
| Rosoxacin | A | ||
| Sabadilla | B | ||
| Salbutamol | B | ||
| Salbutamol Sulphate | B | ||
| Salcatonin | B | ||
| Salcatonin Hydrated Polyacetate | B | ||
| Salmefamol | B | ||
| Salsalate | B | ||
| Saralasin Acetate | B | ||
| Secbutobarbitone | A | ||
| Secbutobarbitone Sodium | A | ||
| Secretin | B | ||
| Selegiline Hydrochloride | B | ||
| Sera and Antisera:— | |||
| Botulin Antitoxin | A | ||
| Diphtheria Antitoxin | A | ||
| Gas-gangrene Antitoxin (Oedematiens) | A | ||
| Gas-gangrene Antitoxin (Perfringens) | A | ||
| Gas-gangrene Antitoxin (Septicum) | A | ||
| Mixed Gas-gangrene Antitoxin Leptospira | A | ||
| Antiserum | A | ||
| Rabies Antiserum | A | ||
| Scorpion Venom Antiserum | A | ||
| Snake Venom Antiserum | A | ||
| Tetanus Antitoxin | A | ||
| Serum Gonadotrophin | A | ||
| Silver Sulphadiazine | A | ||
| Sissomicin | A | ||
| Sissomicin Sulphate | A | ||
| Snake Venoms | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Sodium Acetrizoate | B | ||
| Sodium Aminosalicylate | B | ||
| Sodium Antimonyl-gluconate | B | ||
| Sodium Arsanilate | B | ||
| Sodium Arsenate | B | ||
| Sodium Arsenite | B | 0.013 per cent | |
| Sodium Bromide | B | ||
| Sodium Cromoglycate | B | Administration through the nose | |
| Sodium Ethacrynate | B | ||
| Sodium Fluoride | B | (1) 0.33 per cent | (1) Dentifrices (2) other preparations for use in the prevention of dental caries in the form of:— (a) tablets or drops |
| (b) 0.2 per cent | (b) mouth rinses other than those for daily use | ||
| (c) 0.05 per cent | (c) mouth rinses for daily use | ||
| Sodium Fusidate | A | ||
| Sodium Metrizoate | B | ||
| Sodium Monofluoro-Phosphate | B | 1.14 per cent | Dentifrice |
| Sodium Stibogluconate | B | ||
| Sodium Valproate | B | ||
| Sotalol Hydrochloride | B | ||
| Spectinomycin | A | ||
| Spectinomycin Hydrochloride | A | ||
| Spiramycin | A | ||
| Spiramycin Adipate | A | ||
| Spironolactone | A | ||
| Stannous Flouride | B | 0.62 per cent | Dentifrice |
| Stanolone | A | ||
| Stanozolol | A | ||
| Stilboestrol | A | ||
| Stilboestrol Dipropionate | A | ||
| Streptodornase | B | External | |
| Streptokinase | B | External | |
| Streptomycin | A | ||
| Streptomycin Sulphate | A | ||
| Strophanthin-K | B | ||
| Strychnine | B | ||
| Strychnine Arsenate | B | ||
| Strychnine Hydrochloride | B | ||
| Styramate | B | ||
| Succinyl-sulphathiazole | B | ||
| Sucralfate | B | ||
| Sufentanil Citrate | A | ||
| Sulbactam Sodium | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Sulbactam Tosylate | A | ||
| Sulbenicillin Sodium | A | ||
| Sulconazole Nitrate | B | ||
| Sulfacytine | A | ||
| Sulfadoxine | A | ||
| Sulfamono-methoxine | A | ||
| Sulindac | B | ||
| Suloctidil | B | ||
| Sulphacetamide | A | ||
| Sulphacetamide Sodium | A | ||
| Sulphadiazine | A | ||
| Sulphadiazine Sodium | A | ||
| Sulphadimethoxine | A | ||
| Sulphadimidine | A | ||
| Sulphadimidine Sodium | A | ||
| Sulphafurazole | A | ||
| Sulphafurazole Diethanolamine | A | ||
| Sulphaguanidine | B | ||
| Sulphaloxic Acid | B | ||
| Sulphamerazine | A | ||
| Sulphamerazine Sodium | A | ||
| Sulphamethizole | A | ||
| Sulphamethoxazole | A | ||
| Sulphamethoxy-diazine | A | ||
| Sulphamethoxy-pyridazine | A | ||
| Sulphamethoxy-pyridazine Sodium | A | ||
| Sulphamoxole | A | ||
| Sulphanilamide | A | ||
| Sulphaphenazole | A | ||
| Sulphapyridine | A | ||
| Sulphapyridine Sodium | A | ||
| Sulphasalazine | A | ||
| Sulphathiazole | A | ||
| Sulphathiazole Sodium | A | ||
| Sulphaurea | A | ||
| Sulphinpyrazone | B | ||
| Sulpiride | B | ||
| Sulthiame | B | ||
| Sutoprofen | B | ||
| Suxamethonium Bromide | A | ||
| Suxamethonium Chloride | A | ||
| Suxethonium Bromide | A | ||
| Tacrine Hydrochloride | A | ||
| Talampicillin | A | ||
| Talampicillin Hydrochloride | A | ||
| Talampicillin Napsylate | A | ||
| Tamoxifen | A | ||
| Tamoxifen Citrate | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Taurolidine | B | ||
| Teicoplanin | A | ||
| Temazepam | A | ||
| Teniposide | A | ||
| Tenoxicam | B | ||
| Terazosin Hydrochloride | B | ||
| Terbutaline | B | ||
| Terbutaline Sulphate | B | ||
| Terodiline Hydrochloride | B | ||
| Terlipressin | A | ||
| Testosterone | A | ||
| Testosterone Acetate | A | ||
| Testosterone 17ß Chloral Hemiacetal | A | ||
| Testosterone Cyclohexylpropionate | A | ||
| Testosterone Cypionate | A | ||
| Testosterone Decanoate | A | ||
| Testosterone Enanthate | A | ||
| Testosterone Isocaproate | A | ||
| Testosterone Phenylpropionate | A | ||
| Testosterone Propionate | A | ||
| Testosterone Undecanoate | A | ||
| Tetrabenazine | B | ||
| Tetracosactrin | A | ||
| Tetracosactrin Acetate | A | ||
| Tetracycline | A | ||
| Tetracycline Hydrochloride | A | ||
| Tetracycline Phosphate Complex | A | ||
| Tetrazepam | A | ||
| Thallium Acetate | A | ||
| Thallous Chloride | A | ||
| Thiambutosine | B | ||
| Thiamphenicol | A | ||
| Thiamphenicol Glycinate Hydrochloride | A | ||
| Thiamphenicol Palmitate | A | ||
| Thiethylperazine | B | ||
| Thiethylperazine Malate | B | ||
| Thiethylperazine Maleate | B | ||
| Thiocarlide | B | ||
| Thioguanine | A | ||
| Thiopentone Sodium | A | ||
| Thiopropazate Hydrochloride | B | ||
| Thioproperazine Mesylate | B | ||
| Thioridazine | B | ||
| Thioridazine Hydrochloride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Thiosinamine | A | ||
| Thiotepa | A | ||
| Thiothixene | B | ||
| Thiouracil | B | ||
| Thymoxamine Hydrochloride | B | ||
| Thyroid | B | ||
| Thyrotrophin | A | ||
| Thyroxine Sodium | B | ||
| Tiamulin Fumarate | A | ||
| Tiaprofenic Acid | B | ||
| Tibezonium Iodide | A | ||
| Tibolone | A | ||
| Ticarcillin Sodium | A | ||
| Tienilic Acid | B | ||
| Tigloidine Hydrobromide | B | ||
| Timolol Maleate | B | ||
| Tinidazole | B | ||
| Tioconazole | B | ||
| Tizanidine Hydrochloride | A | ||
| Tobramycin Sulphate | A | ||
| Tocainide Hydrochloride | B | ||
| Tofenacin Hydrochloride | B | ||
| Tofisopam | A | ||
| Tolazamide | B | ||
| Tolazoline Hydrochloride | B | External | |
| Tolobuterol Hydrochloride | B | ||
| Tolbutamide | B | ||
| Tolbutamide Sodium | B | ||
| Tolmetin Sodium | B | ||
| Tramazoline Hydrochloride | B | ||
| Tranexamic Acid | B | ||
| Tranylcypromine Sulphate | A | ||
| Trazodone Hydrochloride | B | ||
| Treosulfan | A | ||
| Tretinoin | B | ||
| Triamcinolone | A | ||
| Triamcinolone Acetonide | A | ||
| Triamcinolone Diacetate | A | ||
| Triamcinolone Hexacetonide | A | ||
| Triamterene | B | ||
| Triazolam | A | ||
| Triclofos Sodium | B | ||
| Trifluoperazine | B | ||
| Trifluoperazine Hydrochloride | B | ||
| Trifluperidol | A | ||
| Trifluperidol Hydrochloride | A | ||
| Trilostane | A | ||
| Trimazosin Hydrochloride | B | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Trimeprazine | B | ||
| Trimeprazine Tartrate | B | ||
| Trimetaphan Camsylate | B | ||
| Trimetazidine | B | ||
| Trimetazidine Hydrochloride | B | ||
| Trimethoprim | A | ||
| Trimipramine Maleate | A | ||
| Trimipramine Mesylate | A | ||
| Tropicamide | B | ||
| Troxidone | B | ||
| L-Tryptophan | B | (1) Dietary or nutritive use (2) Any external use | |
| Tubocurarine | |||
| Chloride | A | ||
| Tulobuterol | |||
| Hydrochloride | A | ||
| Tyrothricin | A | Throat lozenges and throat pastilles | |
| Uramustine | A | ||
| Urapidil | B | ||
| Urea Stibamine | B | ||
| Urethane | A | ||
| Uridine-5-Triphosphoric Acid | B | ||
| Urofollitrophin | A | ||
| Urokinase | B | ||
| Ursodeoxycholic Acid | B | ||
| Vaccines:— | |||
| Anthrax Vaccine (Bacillus Anthracis) | A | ||
| Bacillus Calmette-Guerin Vaccine | A | ||
| Percutaneous Bacillus Calmette-Guerin Vaccine | A | ||
| Cholera Vaccine | A | ||
| Diphtheria Vaccine | A | ||
| Adsorbed Diphtheria Vaccine | A | ||
| Diphtheria, and Tetanus Vaccine | A | ||
| Adsorbed Diphtheria and Tetanus Vaccine | A | ||
| Diphtheria, Tetanus and Pertussis Vaccine | A | ||
| Adsorbed Diphtheria, Tetanus and Pertussis Vaccine | A | ||
| Diphtheria, Tetanus and Poliomyelitis Vaccine | A | ||
| Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine | A | ||
| Eltor Vaccine | A | ||
| Influenza Vaccine | A | ||
| Measles Vaccine (Live Attenuated) | A | ||
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Pertussis Vaccine | A | ||
| Plague Vaccine | A | ||
| Pneumococcal Vaccine (Bacterial Antigen) | A | ||
| Poliomyelitis Vaccine (Inactivated) | A | ||
| Poliomyelitis Vaccine (Oral) | A | ||
| Rabies Vaccine | A | ||
| Rubella Vaccine (Live Attenuated) | A | ||
| Smallpox Vaccine Dried Smallpox | A | ||
| Vaccine | A | ||
| Schick Control | A | ||
| Schick Test Toxin | A | ||
| Tetanus Vaccine | A | ||
| Adsorbed Tetanus Vaccine | A | ||
| Tetanus and Pertussis Vaccine | A | ||
| Tuberculin Purified Protein Derivative | A | ||
| Old Tuberculin | A | ||
| Typhoid Vaccine | A | ||
| Typhoid and Tetanus Vaccine | A | ||
| Typhoid-paratyphoid A and B Vaccine | A | ||
| Typhoid-paratyphoid A and B and Cholera Vaccine | A | ||
| Typhoid- | |||
| paratyphoid A and B and Tetanus Vaccine | A | ||
| Typhus Vaccine | A | ||
| Yellow Fever Vaccine | A | ||
| Valproic Acid | B | ||
| Vancomycin Hydrochloride | A | ||
| Vasopressin | A | ||
| Vasopressin Tannate | A | ||
| Vecuronium Bromide | A | ||
| Veralipride | B | ||
| Verapamil Hydrochloride | B | ||
| Veratrine | B | ||
| Veratrum (Green and White) | B | ||
| Vidarabine | A | ||
| Viloxazine Hydrochloride | B | ||
| Vinblastine Sulphate | A | ||
| Vincristine Sulphate | A | ||
| Vindesine Sulphate | A | ||
| Viomycin Pantothenate | A | ||
| Viomycin Sulphate | A | ||
| Vitamin A | B | (1) Internal (2) External | |
| --- | --- | --- | --- |
| Circumstances excluding medical preparations from prescription control | Circumstances excluding medical preparations from prescription control | ||
| Column 1 | Column 2 | Column 3 | Column 4 |
| Substance | Part in Schedule | Maximum Strength | Use, pharmaceutical form or manner of administration |
| Vitamin A Acetate | B | (1) Internal (2) External | |
| Vitamin A Palmitate | B | (1) Internal (2) External | |
| Warfarin | B | ||
| Warfarin Sodium | B | ||
| Xamoterol Fumarate | A | ||
| Xipamide Yohimbine | B | ||
| Hydrochloride | B | ||
| Zimeldine Hydrochloride | A | ||
| Zomepirac Sodium | B | ||
| Zopiclone | A |
This document does not substitute the official text published in the Irish Statute Book. We accept no responsibility for any inaccuracies arising from the transcription of the original into this format.
This text is published under Irish Statute Book's own terms of reuse, not a Legalize or public-domain licence.
Irish Statute Book
CC-BY 4.0 (Oireachtas Open Data PSI Licence)
Contains Irish Public Sector Information licensed under the Oireachtas (Houses of the Oireachtas) Open Data PSI Licence / Creative Commons Attribution 4.0 International, sourced from https://www.irishstatutebook.ie.